GTC
Ghost Tree Capital Portfolio holdings
AUM
$276M
This Quarter Return
-15.4%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$287M
AUM Growth
+$287M
(-25%)
Cap. Flow
-$19.6M
Cap. Flow
% of AUM
-6.82%
Top 10 Holdings %
Top 10 Hldgs %
55.29%
Holding
54
New
11
Increased
10
Reduced
15
Closed
11
Top Buys
| 1 |
Invesco CurrencyShares British Pound Sterling Trust
FXB
|
$12.6M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$12.5M |
| 3 |
SAGE
Sage Therapeutics
SAGE
|
$11.2M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$10.4M |
| 5 |
Pacira BioSciences
PCRX
|
$9.52M |
Top Sells
| 1 |
Acadia Pharmaceuticals
ACAD
|
$20M |
| 2 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$15.8M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
$10.9M |
| 4 |
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
|
$9.02M |
| 5 |
Ascendis Pharma
ASND
|
$7.22M |
Sector Composition
| 1 | Healthcare | 87.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BPMC
1
DELISTED
Blueprint Medicines
BPMC
| $23.9M | 6.08% | 325,000 -50,000 | -13% | -$3.67M |
|
|
MRTX
2
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $21.4M | 5.46% | 275,000 -60,000 | -18% | -$4.67M |
|
3
Sarepta Therapeutics
SRPT
$1.78B
| $16.6M | 4.22% | 220,000 -70,000 | -24% | -$5.27M |
|
|
SAGE
4
DELISTED
Sage Therapeutics
SAGE
| $15.4M | 3.93% | 110,000 +80,000 | +267% | +$11.2M |
|
|
BHVN
5
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $14.6M | 3.72% | 350,000 +250,000 | +250% | +$10.4M |
|
|
6
Ascendis Pharma
ASND
$11.8B
| $14.4M | 3.68% | 150,000 -75,000 | -33% | -$7.22M |
|
7
Amicus Therapeutics
FOLD
$2.34B
| $13.7M | 3.48% | 1,705,000 +255,000 | +18% | +$2.05M |
|
8
Axsome Therapeutics
AXSM
$6.05B
| $13.7M | 3.48% | 675,000 -175,000 | -21% | -$3.54M |
|
|
9
Invesco CurrencyShares British Pound Sterling Trust
FXB
$91M
| $12.6M | 3.21% | +105,600 | New | +$12.6M |
|
|
10
BioMarin Pharmaceuticals
BMRN
$11.2B
| $12.5M | 3.18% | +185,000 | New | +$12.5M |
|
|
IMMU
11
DELISTED
Immunomedics Inc
IMMU
| $9.61M | 2.45% | 725,000 +125,000 | +21% | +$1.66M |
|
|
12
Pacira BioSciences
PCRX
$1.2B
| $9.52M | 2.42% | +250,000 | New | +$9.52M |
|
13
Iovance Biotherapeutics
IOVA
$807M
| $9.1M | 2.32% | 500,000 +350,000 | +233% | +$6.37M |
|
14
Adverum Biotechnologies
ADVM
$64.6M
| $7.9M | 2.01% | +1,450,000 | New | +$7.9M |
|
15
Rocket Pharmaceuticals
RCKT
$354M
| $7.28M | 1.86% | 625,000 +165,000 | +36% | +$1.92M |
|
|
ATNX
16
DELISTED
Athenex, Inc. Common Stock
ATNX
| $6.36M | 1.62% | +522,500 | New | +$6.36M |
|
17
argenx
ARGX
$43.6B
| $5.7M | 1.45% | 50,000 -50,000 | -50% | -$5.7M |
|
18
Fate Therapeutics
FATE
$120M
| $5.44M | 1.39% | +350,000 | New | +$5.44M |
|
|
TPTX
19
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $4.7M | 1.2% | +125,000 | New | +$4.7M |
|
|
MNTA
20
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $4.54M | 1.16% | 350,000 -150,000 | -30% | -$1.94M |
|
|
KDMN
21
DELISTED
Kadmon Holdings, Inc.
KDMN
| $4.41M | 1.12% | 1,750,000 -350,000 | -17% | -$882K |
|
22
Invesco CurrencyShares Swiss Franc Trust
FXF
$376M
| $4.4M | 1.12% | 47,500 -44,700 | -48% | -$4.14M |
|
23
Milestone Pharmaceuticals
MIST
$156M
| $4.38M | 1.12% | 235,000 -5,000 | -2% | -$93.3K |
|
|
AERI
24
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $4.33M | 1.1% | +225,000 | New | +$4.33M |
|
25
BioCryst Pharmaceuticals
BCRX
$1.74B
| $4.3M | 1.1% | 1,500,000 -1,000,000 | -40% | -$2.87M |
|